The Microbiota–Gut–Brain Axis and Neurological Disorders: A Comprehensive Review
Mohammed M. Nakhal,
No information about this author
Lidya K. Yassin,
No information about this author
Rana Alyaqoubi
No information about this author
et al.
Life,
Journal Year:
2024,
Volume and Issue:
14(10), P. 1234 - 1234
Published: Sept. 26, 2024
Microbes
have
inhabited
the
earth
for
hundreds
of
millions
years
longer
than
humans.
The
microbiota-gut-brain
axis
(MGBA)
represents
a
bidirectional
communication
pathway.
These
communications
occur
between
central
nervous
system
(CNS),
enteric
(ENS),
and
emotional
cognitive
centres
brain.
field
research
on
gut-brain
has
grown
significantly
during
past
two
decades.
Signalling
occurs
gut
microbiota
brain
through
neural,
endocrine,
immune,
humoral
pathways.
A
substantial
body
evidence
indicates
that
MGBA
plays
pivotal
role
in
various
neurological
diseases.
include
Alzheimer's
disease
(AD),
autism
spectrum
disorder
(ASD),
Rett
syndrome,
attention
deficit
hyperactivity
(ADHD),
non-Alzheimer's
neurodegeneration
dementias,
fronto-temporal
lobe
dementia
(FTLD),
Wilson-Konovalov
(WD),
multisystem
atrophy
(MSA),
Huntington's
chorea
(HC),
Parkinson's
(PD),
multiple
sclerosis
(MS),
amyotrophic
lateral
(ALS),
temporal
epilepsy
(TLE),
depression,
schizophrenia
(SCZ).
Furthermore,
correlation
therapeutics
will
be
discussed.
Conversely,
mood
delivery,
exercise,
psychotropic
agents,
stress,
neurologic
drugs
can
influence
MGBA.
By
understanding
MGBA,
it
may
possible
to
facilitate
into
microbial-based
interventions
therapeutic
strategies
Language: Английский
Health and aging trajectories: shared and competing risks and resiliencies for chronic diseases associated with aging. A NIH-wide workshop
Ilsa I. Rovira,
No information about this author
Arya Biragyn,
No information about this author
LaVerne L. Brown
No information about this author
et al.
Frontiers in Public Health,
Journal Year:
2025,
Volume and Issue:
13
Published: May 1, 2025
Language: Английский
From the Gut to the Brain: Is Microbiota a New Paradigm in Parkinson’s Disease Treatment?
Cells,
Journal Year:
2024,
Volume and Issue:
13(9), P. 770 - 770
Published: April 30, 2024
Parkinson’s
disease
(PD)
is
recognized
as
the
second
most
prevalent
primary
chronic
neurodegenerative
disorder
of
central
nervous
system.
Clinically,
PD
characterized
a
movement
disorder,
exhibiting
an
incidence
and
mortality
rate
that
increasing
faster
than
any
other
neurological
condition.
In
recent
years,
there
has
been
growing
interest
concerning
role
gut
microbiota
in
etiology
pathophysiology
PD.
The
establishment
brain–gut
axis
now
real,
with
evidence
denoting
bidirectional
communication
between
brain
through
metabolic,
immune,
neuronal,
endocrine
mechanisms
pathways.
Among
these,
vagus
nerve
represents
direct
form
gut.
Given
potential
interactions
bacteria
drugs,
it
observed
therapies
for
can
have
impact
on
composition
microbiota.
Therefore,
scope
present
review,
we
will
discuss
current
understanding
whether
this
may
be
new
paradigm
treating
devastating
disease.
Language: Английский